Vestal Point Capital »

Jazz Pharmaceuticals shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Jazz Pharmaceuticals (JAZZ) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Jazz Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Jazz Pharmaceuticals held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jazz Pharmaceuticals by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $160M 1.5M 106.73

More positions owned by Vestal Point Capital

Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Ascendis Pharma A/S Sponsored Adr (ASND)
Ultragenyx Pharmaceutical (RARE)
Globus Medical Cl A (GMED)
Insmed Com Par $.01 (INSM)
BeiGene Sponsored Adr (BGNE)
Soleno Therapeutics (SLNO)
EXACT Sciences Corporation (EXAS)
Arcellx Common Stock (ACLX)
Immatics NV SHS (IMTX)
Janux Therapeutics (JANX)
Astria Therapeutics (ATXS)
Kalvista Pharmaceuticals (KALV)
Savara (SVRA)

View all positions for Vestal Point Capital

Top funds holding Jazz Pharmaceuticals

Vanguard Group
BlackRock
LSV Asset Management
State Street Corporation
Jpmorgan Chase & Co
Vestal Point Capital
Polaris Capital Management
Baupost Group
Dimensional Fund Advisors
Geode Capital Management
Franklin Resources
Renaissance Technologies
EcoR1 Capital
Swedbank AB
Thompson, Siegel, & Walmsley

View all funds holding Jazz Pharmaceuticals